Streetbeat News

Equity Actions

LBPH

Longboard Pharmaceuticals has priced an upsized public offering of 10 million common shares at $21 per share, raising $210 million in capital. This move could indicate the company's need for capital to fund its operations or growth initiatives.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 7:03 am

KROS

Keros Therapeutics has announced the pricing of an upsized public offering of 3.5 million common shares at $40 per share, aiming to raise $140 million.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 7:01 am

SLS

SELLAS Life Sciences plans to launch a public offering of common stock and warrants to fund ongoing operations, including clinical development of product candidates, working capital, and general corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 6:54 am

BTCUSD

Robert Kiyosaki, author of 'Rich Dad Poor Dad', is urging his followers to pay attention to the upcoming Bitcoin halving, an event that reduces the rate of new Bitcoin creation by half. He believes that Bitcoin owners could become wealthier due to the Federal Reserve's monetary policy changes. Kiyosaki advocates for long-term investment in Bitcoin and suggests diversifying with assets like gold, silver, and Bitcoin to protect wealth during economic downturns. BTC was trading at $43,161, down 4.61% on Wednesday.

Portfolio Pulse from Mehab Qureshi

January 04, 2024 | 4:00 am

ARKK

ARKW

COIN

TSLA

Ark Invest, led by Cathie Wood, has made significant trades by purchasing approximately $25 million in Tesla Inc (TSLA) shares and selling a nearly equal amount in Coinbase Global Inc. (COIN) shares. The transactions were conducted through ARK Innovation ETF (ARKK) and ARK Next Generation Internet ETF (ARKW). The Tesla purchase reflects Ark's confidence in Tesla's AI and Cybertruck prospects, while the Coinbase sale coincides with a drop in Bitcoin's value following regulatory concerns.

Portfolio Pulse from Benzinga Neuro

January 04, 2024 | 2:36 am

SLS

Sellas Life Sciences (SLS) and Cantor Fitzgerald & Co. mutually agreed to terminate their Controlled Equity Offering Sales Agreement, initially established on April 16, 2021, as disclosed in an 8-K filing on January 2.

Portfolio Pulse from Charles Gross

January 03, 2024 | 10:37 pm

SPY

Jordan Belfort, known as 'The Wolf of Wall Street,' advised against following investing experts, including Jim Cramer, and picking individual stocks. He criticized active management due to fees, commissions, and tax liabilities. Instead, Belfort recommended buying and holding high-quality stocks, reinvesting dividends, and compounding growth. He suggested ETFs like SPDR S&P 500 (NYSE:SPY) for consistent profitability and stressed the importance of passive investing and diversification with bond funds.

Portfolio Pulse from Erica Kollmann

January 03, 2024 | 10:13 pm

VERI

Veritone Inc has filed with the SEC to register up to 3 million shares of common stock for potential sale by existing stockholders. This shelf registration allows stockholders to sell these shares at any time, which could potentially dilute current shareholders' equity and affect the stock price.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 9:40 pm

VSAC

VSACU

Vision Sensing Acquisition, a SPAC company, has extended its deadline to complete an initial business combination to February 3, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 9:33 pm

FEBO

Fenbo Holdings has announced the appointment of Meng Derong as Co-Chairman and Independent Non-Executive Director, effective January 1, 2024. This strategic move could signal a strengthening of the company's governance and oversight.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 9:32 pm